Your browser doesn't support javascript.
loading
Association between cell-bound blood amyloid-ß(1-40) levels and hippocampus volume.
Sotolongo-Grau, Oscar; Pesini, Pedro; Valero, Sergi; Lafuente, Asunción; Buendía, Mar; Pérez-Grijalba, Virginia; José, Itziar San; Ibarria, Marta; Tejero, Miguel A; Giménez, Joan; Hernández, Isabel; Tárraga, Lluís; Ruiz, Agustín; Boada, Mercé; Sarasa, Manuel.
Afiliación
  • Sotolongo-Grau O; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain.
  • Pesini P; Araclon Biotech Ltd, Via Hispanidad 21, Zaragoza, 50009, Spain.
  • Valero S; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain ; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron, 119-129, B
  • Lafuente A; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain.
  • Buendía M; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain.
  • Pérez-Grijalba V; Araclon Biotech Ltd, Via Hispanidad 21, Zaragoza, 50009, Spain.
  • José IS; Araclon Biotech Ltd, Via Hispanidad 21, Zaragoza, 50009, Spain.
  • Ibarria M; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain.
  • Tejero MA; Department of Diagnostic Imaging, Clínica Corachan, Buïgas, 19, Barcelona, 08017, Spain.
  • Giménez J; Department of Diagnostic Imaging, Clínica Corachan, Buïgas, 19, Barcelona, 08017, Spain.
  • Hernández I; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain.
  • Tárraga L; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain.
  • Ruiz A; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain.
  • Boada M; Alzheimer Research Center and Memory Clinic, Fundació ACE Memory Clinic, Institut Català de Neurociències Aplicades, Marquès de Sentmenat, 57, Barcelona, 08029, Spain.
  • Sarasa M; Araclon Biotech Ltd, Via Hispanidad 21, Zaragoza, 50009, Spain.
Alzheimers Res Ther ; 6(5-8): 56, 2014.
Article en En | MEDLINE | ID: mdl-25484928
INTRODUCTION: The identification of early, preferably presymptomatic, biomarkers and true etiologic factors for Alzheimer's disease (AD) is the first step toward establishing effective primary and secondary prevention programs. Consequently, the search for a relatively inexpensive and harmless biomarker for AD continues. Despite intensive research worldwide, to date there is no definitive plasma or blood biomarker indicating high or low risk of conversion to AD. METHODS: Magnetic resonance imaging and ß-amyloid (Aß) levels in three blood compartments (diluted in plasma, undiluted in plasma and cell-bound) were measured in 96 subjects (33 with mild cognitive impairment, 14 with AD and 49 healthy controls). Pearson correlations were completed between 113 regions of interest (ROIs) (45 subcortical and 68 cortical) and Aß levels. Pearson correlation analyses adjusted for the covariates age, sex, apolipoprotein E (ApoE), education and creatinine levels showed neuroimaging ROIs were associated with Aß levels. Two statistical methods were applied to study the major relationships identified: (1) Pearson correlation with phenotype added as a covariate and (2) a meta-analysis stratified by phenotype. Neuroimaging data and plasma Aß measurements were taken from 630 Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects to be compared with our results. RESULTS: The left hippocampus was the brain region most correlated with Aß(1-40) bound to blood cell pellets (partial correlation (pcor) = -0.37, P = 0.0007) after adjustment for the covariates age, gender and education, ApoE and creatinine levels. The correlation remained almost the same (pcor = -0.35, P = 0.002) if phenotype is also added as a covariate. The association between both measurements was independent of cognitive status. The left hemisphere entorhinal cortex also correlated with Aß(1-40) cell-bound fraction. AB128 and ADNI plasma Aß measurements were not related to any brain morphometric measurement. CONCLUSIONS: Association of cell-bound Aß(1-40) in blood with left hippocampal volume was much stronger than previously observed in Aß plasma fractions. If confirmed, this observation will require careful interpretation and must be taken into account for blood amyloid-based biomarker development.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Res Ther Año: 2014 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Res Ther Año: 2014 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido